Investor Relations

Since 1979, Plexus has been partnering with companies to create the products that build a better world. We are a team of over 19,000, providing global Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing, and Aftermarket Services. Plexus is a global leader that specializes in serving customers in industries with highly complex products and demanding regulatory requirements. Plexus delivers customer service excellence to leading global companies by providing innovative, comprehensive solutions throughout the product’s lifecycle.

Copyright West LLC. Minimum 15 minutes delayed.

Recent News

Plexus Announces Fiscal Fourth Quarter and Fiscal Year 2019 Financial Results

Record fiscal fourth quarter revenue of $810 million and record fiscal 2019 revenue of $3.2 billion Fiscal fourth quarter GAAP diluted EPS of $1.23 , including $0.19 of stock-based compensation expense Non-GAAP adjusted diluted EPS of $0.93 , excluding a non-cash benefit of $0.35 per share related

Read More

Plexus Sets Fiscal Fourth Quarter 2019 Earnings Release Date

NEENAH, Wis. , Sept. 26, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today it will release its fiscal fourth quarter 2019 results after the market closes on Wednesday, October 23 , 2019.  Plexus’ management will host a conference call to discuss its fourth quarter results on Thursday,

Read More

Plexus Announces $50 Million Share Repurchase Program

NEENAH, Wis. , Aug. 20, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today that its Board of Directors has approved a new share repurchase program under which the Company is authorized to repurchase up to $50 million of its common stock beginning upon expiration of the Company’s

Read More

Plexus Announces Fourth Facility Certified to Manufacture Class III Finished Medical Devices

NEENAH, Wis., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today that its Azteca Manufacturing facility, located in Guadalajara, Mexico, achieved Federal Drug Administration (FDA) approval to manufacture finished, Class III medical devices.

Read More

Events and Presentations

IR Contact

Sign up to get investor alerts delivered to your inbox.

Sign up